U.S. Markets open in 8 hrs 43 mins

How Did Jazz Pharmaceuticals Perform in the Second Quarter?

Daniel Collins
How Did Jazz Pharmaceuticals Perform in the Second Quarter?

On August 7, Jazz Pharmaceuticals (JAZZ) released its second-quarter 2018 financial results. Jazz Pharmaceuticals reported revenues of $500.5 million in Q2 2018 compared to $394.4 million in Q2 2017, a ~27% YoY increase and a ~13% sequential increase.